Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Clin Lab Med ; 20(2): 235-55, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10863639

ABSTRACT

Like many viruses, HPV is a fascinating organism. It is extremely difficult to grow in vitro; but once an individual becomes infected with HPV, it can be difficult or even impossible to eradicate. HPV is associated with mild to moderate disease that even in the absence of therapy may spontaneously regress. On the other hand, some HPV infections progress to cancer, which can be fatal if treatment is delayed. The reader is invited to learn more about the aspects of the biology, diagnosis, and treatment of HPV in the articles that follow.


Subject(s)
Papillomaviridae , Papillomavirus Infections , Tumor Virus Infections , Condylomata Acuminata/virology , Female , Humans , Papillomaviridae/genetics , Papillomaviridae/immunology , Papillomavirus Infections/epidemiology , Papillomavirus Infections/transmission , Sexually Transmitted Diseases , Tumor Virus Infections/epidemiology , Tumor Virus Infections/transmission , Uterine Cervical Neoplasms/virology , Warts/virology
2.
Leuk Res ; 24(5): 417-26, 2000 May.
Article in English | MEDLINE | ID: mdl-10785264

ABSTRACT

The outcome of patients diagnosed myelodysplastic syndromes (MDS) between 1990 and 1997 from William Beaumont Hospital (WBH) was analyzed according to the International Prognostic Scoring System (IPSS) risk categorization. A retrospective study of 195 MDS patients wa s performed. Seventy-nine patients with MDS, in whom a karyotype was obtained and with an adequate follow-up were included in the final analysis. Cases of proliferative CMML (WBC > 12x10(9)/l) were excluded from the study. The overall median survival was 3.1 years, and median survival stratified by IPSS was 3.4, 4.1 and 0.5 years for the INT-1, INT-2 and high risk group and not yet reached for the low risk group. The overall survival by IPSS subcategorization were 6.88, 5.29, 5.30 and 2.12 years for the low, INT-1, INT-2, and high risk groups respectively. Cytogenetics were significant in predicting the overall survival. The IPSS score stratified patients into risk categories for development of AML. The risk of development into AML was 8, 8, 33 and 54% for the low, INT-1, INT-2 and high risk groups, respectively. We conclude that IPSS score can be useful in predicting survival and AML evolution in some MDS patients.


Subject(s)
Myelodysplastic Syndromes/physiopathology , Acute Disease , Aged , Female , Hospitals, Community , Humans , Leukemia, Myeloid/etiology , Male , Middle Aged , Myelodysplastic Syndromes/complications , Myelodysplastic Syndromes/mortality , Prognosis , Retrospective Studies , Risk , Survival Analysis
3.
Am J Surg Pathol ; 23(9): 1075-81, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10478667

ABSTRACT

The morphologic findings in mildly active colonic Crohn's disease (CD) include crypt disarray, patchy edema, and small lymphoid aggregates with neutrophils, sometimes associated with aphthous ulcers. We describe four patients with CD whose colonic biopsies focally showed a lymphocytic colitis morphology, and one patient with CD whose biopsies showed a collagenous colitis morphology. The lymphocytic and collagenous colitis patterns of injury preceded the eventual clinical pathologic diagnosis of CD in four patients. Colonoscopic abnormalities were found in four patients. The lymphocytic colitis pattern was focal, involving some biopsy fragments, whereas other biopsy fragments were normal or had minimal nonspecific inflammation. In one patient, moderate numbers of neutrophils were admixed with the lymphoplasmacytic infiltrates. The presence of colonoscopic abnormalities, focal changes, and moderate admixed neutrophils could assist in the distinction from lymphocytic or collagenous colitis, both of which are colonoscopically normal, usually diffuse, and devoid of, or contain only a sparse number of, neutrophils. A limited number of biopsy fragments may be incorrectly interpreted as lymphocytic or collagenous colitis. The temporal relationships suggest that these morphologic patterns precede typical active CD.


Subject(s)
Colitis/pathology , Colon/pathology , Crohn Disease/pathology , Adolescent , Adult , Biopsy , Colitis/classification , Colitis/diagnosis , Crohn Disease/diagnosis , Diagnosis, Differential , Female , Humans , Male , Middle Aged , Retrospective Studies
4.
Int J Cancer ; 59(1): 78-82, 1994 Oct 01.
Article in English | MEDLINE | ID: mdl-7927908

ABSTRACT

We report expression of the wt1 (Wilms' tumor) gene by cultured human melanoma cells. Using RNA polymerase chain reaction analysis, wt1 transcripts were detected in 7 of 9 melanoma cell lines but not in 5 normal melanocyte strains. In Northern blot analysis, steady-state wt1 mRNA levels were found in 2 of 4 melanoma lines but not in normal melanocytes. Sequence analysis of the wt1 cDNA expressed by melanoma cell line WM 902-B revealed the presence of 4 previously published splice variants but no evidence for mutations in the coding region. Previous work has shown that WT1 modulates transcription after binding to the early growth response (EGR)-1 sites present in the platelet-derived growth factor (PDGF)-A chain promoter; the PDGF-A chain gene is known to be expressed by various melanoma cell lines. Based on these findings, we studied the relationship of wt1 and PDGF-A chain gene expression in melanoma cell lines. Co-expression of the wt1 and the PDGF-A chain genes was observed in 2 melanoma cell lines with mutated p53 but not in 2 melanoma cell lines with wild-type p53; this result is consistent with a previous report showing that, in the context of absent or mutated p53, WT1 acts as a transcriptional activator, whereas in the presence of wild-type p53 it acts as a repressor.


Subject(s)
Gene Expression , Genes, Wilms Tumor , Melanocytes/metabolism , Melanoma/metabolism , Base Sequence , Blotting, Northern , DNA, Complementary/chemistry , Genes, p53 , Humans , Melanoma/genetics , Molecular Sequence Data , Mutation , Platelet-Derived Growth Factor/genetics , Polymerase Chain Reaction , RNA Splicing , RNA, Messenger/metabolism , Tumor Cells, Cultured
5.
Int J Cancer ; 54(1): 159-65, 1993 Apr 22.
Article in English | MEDLINE | ID: mdl-8478142

ABSTRACT

Malignant melanoma cells can differentiate spontaneously in vivo and in vitro into cells with a finite lifespan. Analysis of differentiating cells from primary melanomas in culture revealed a flat, fibroblast-like morphology and expression of the fibroblast-associated marker leucine aminopeptidase (LAP). Differentiation was also observed in a minor sub-population of permanent cell lines derived from metastatic lesions. An experimental model of melanoma cell differentiation was then developed, using the pyrimidine analog bromodeoxyuridine (BUdR). BUdR-treated cells had a flat morphology, were contact-inhibited, had up to 20-fold increased surface area, expressed LAP, no longer proliferated anchorage-independently in soft agar, and 3 out of 4 cell lines were non-tumorigenic in athymic nude mice. Our results show that models of differentiation of melanoma cells can be established that help to define pathways of differentiation.


Subject(s)
Melanoma/pathology , Animals , Bromodeoxyuridine/pharmacology , Cell Differentiation/drug effects , Gene Expression , Genes, myc , Humans , In Vitro Techniques , Leucyl Aminopeptidase/metabolism , Mice , Mice, Nude , Neoplasm Transplantation , RNA, Messenger/genetics , RNA, Neoplasm/genetics , Transplantation, Heterologous , Tumor Cells, Cultured
6.
J Invest Dermatol ; 100(3): 281S-287S, 1993 Mar.
Article in English | MEDLINE | ID: mdl-8440904

ABSTRACT

Cells isolated from congenital melanocytic nevi and cultured in vitro have growth characteristics that resemble their premalignant stage in situ. A serum-free, chemically defined medium has been developed that allows continuous growth of established nevus cultures for up to several months. Like primary melanoma cells, nevus cells in high-calcium-containing W489 medium require insulin for growth. In contrast to melanoma cells, nevus cells in serum-free medium require the presence of alpha-melanocyte-stimulating hormone, which enhanced intracellular levels of cyclic adenosine monophosphate. In contrast to the requirements of normal human melanocytes from newborn foreskin, congenital nevus cells grow with less dependency on basic fibroblast growth factor (bFGF). Nevus cultures contain bFGF-like activity, and they express bFGF mRNA. Nevic cells of compound nevi also express bFGF mRNA in situ but only in the junctional areas. These results indicate that bFGF plays an important growth regulatory role for nevus cells in vitro and in vivo.


Subject(s)
Nevus/pathology , Skin Neoplasms/pathology , Base Sequence , Calcium/analysis , Cell Division , Culture Media, Serum-Free/chemistry , Fibroblast Growth Factor 2/analysis , Fibroblast Growth Factor 2/genetics , Humans , Melanocyte-Stimulating Hormones/pharmacology , Melanoma/etiology , Molecular Sequence Data , Nevus/chemistry , Nevus/congenital , RNA, Messenger/analysis , Skin Neoplasms/chemistry , Skin Neoplasms/congenital , Tumor Cells, Cultured/drug effects
7.
Int J Cancer ; 50(2): 274-80, 1992 Jan 21.
Article in English | MEDLINE | ID: mdl-1730521

ABSTRACT

During serial passage of the colorectal carcinoma cell line SW1116 in athymic nude mice, we selected 2 variants that metastasized to the lungs and liver. The metastatic capacity of these in vivo variant cell lines was associated with their ability to (1) grow under growth-factor-deprived conditions, (2) invade and transgress a reconstructed basement membrane with high effectiveness, and (3) produce higher activities of the substrate-degrading enzymes collagenase and plasminogen activator as compared to parental cells. To assess the relative contribution of growth-factor-independence and high levels of invasiveness/motility to the metastatic phenotype, variants of 6 colorectal carcinomas were selected in vitro by adaptation to a growth-factor-free culture medium followed by selection of highly invasive cells in chemoinvasion assays. Four out of 6 cell lines selected for growth-factor-independence showed significantly higher levels of invasiveness through reconstructed membranes, suggesting co-segregation of growth-factor-independence and high levels of invasiveness in vitro. Using an in vitro chemoinvasion assay, 2 poorly and 1 highly invasive cell line were further selected for invasiveness. After 6 selection passages, all cell lines were highly invasive and showed high motility rates. However, when injected s.c. into athymic nude mice to test their metastatic capacity in vivo, double-selected variant cell lines did not form spontaneous metastases. Our results indicate that growth-factor-independence and high levels of invasiveness, although associated with the metastatic phenotype, are not sufficient for experimental metastasis formation of colorectal carcinoma cells in vivo.


Subject(s)
Colorectal Neoplasms/pathology , Growth Substances/pharmacology , Animals , Cell Division/drug effects , Cell Division/physiology , Humans , Liver Neoplasms, Experimental/secondary , Lung Neoplasms/secondary , Mice , Mice, Inbred BALB C , Mice, Nude , Neoplasm Invasiveness/pathology , Neoplasm Metastasis/pathology , Neoplasm Transplantation , Phenotype , Tumor Cells, Cultured
8.
Neoplasma ; 38(1): 49-55, 1991.
Article in English | MEDLINE | ID: mdl-2011209

ABSTRACT

An experimental liver metastasis model using the HT-29 human colon carcinoma cell line is described. The tumor xenograft in immunosuppressed mice preserved the histological type as well as the human and gastrointestinal markers (HLA-I, CEA). This model seems to be suitable for the development of new therapeutic protocols as well as for the study of metastasizing of a frequent human tumor type.


Subject(s)
Colonic Neoplasms/pathology , Liver Neoplasms/secondary , Animals , Carcinoembryonic Antigen/analysis , Cell Line , Colonic Neoplasms/immunology , Disease Models, Animal , Humans , Immune Tolerance , Liver/pathology , Liver Neoplasms/immunology , Mice , Neoplasm Transplantation , Spleen/pathology , Tumor Cells, Cultured/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...